Bayer AG BAYN-DE:XETRA

*Data is delayed | EUR
Last | 10/22/21 CEST
48.32quote price arrow up+0.13 (+0.27%)
Volume
1,491,925
52 week range
39.91 - 57.73
Loading...
  • Open48.18
  • Day High48.53
  • Day Low48.05
  • Prev Close48.19
  • 52 Week High57.73
  • 52 Week High Date05/14/21
  • 52 Week Low39.91
  • 52 Week Low Date10/30/20

Key Stats

  • Market Cap13,881.65M
  • Shares Out982.42M
  • 10 Day Average Volume2.68M
  • Dividend2.00
  • Dividend Yield4.14%
  • Beta-
  • YTD % Change0.34

KEY STATS

  • Open48.18
  • Day High48.53
  • Day Low48.05
  • Prev Close48.19
  • 52 Week High57.73
  • 52 Week High Date05/14/21
  • 52 Week Low39.91
  • 52 Week Low Date10/30/20
  • Market Cap13,881.65M
  • Shares Out982.42M
  • 10 Day Average Volume2.68M
  • Dividend2.00
  • Dividend Yield4.14%
  • Beta-
  • YTD % Change0.34

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date04/28/2021
  • Div Amount2.00
  • Split Date-
  • Split Factor-

Latest On Bayer AG

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Bayer AG is a German-based life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and ophthalmology, as well as radiopharmacology and others. The company is focusing on their oncology platform o Targeted Alpha Therapies...
Wolfgang Nickl
Chief Financial Officer
Address
Kaiser-Wilhelm-Allee 1
Leverkusen
51373
Germany